[
  {
    "id": "example_1",
    "input_text": "Indication: RUL posterior nodule (2.3cm). High risk surgical candidate.\nProcedure: EMN Bronchoscopy + Microwave Ablation.\nEquipment: SuperDimension, Emprint 2.0 probe.\nAction: Navigated to RB1. Confirmed w/ R-EBUS & Cone Beam. Ablated 65W x 5 min (Max temp 85C).\nResult: Hyperechoic zone on R-EBUS (necrosis).",
    "ideal_output": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\n\nCC Referred Physician: [Name / Self, Referred] \n\nINDICATION FOR OPERATION [Patient Name] is a [Age]-year-old [Sex] who presents with a 2.3 cm RUL posterior nodule.  The patient is a high-risk surgical candidate requiring bronchoscopic treatment. The nature, purpose, risks, benefits, and alternatives to bronchoscopy and ablation were discussed with the patient in detail. The patient wished to proceed and informed consent was obtained. \n\nCONSENT Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient or surrogate. Consent was signed and witnessed by an assisting medical professional. \n\nPREOPERATIVE DIAGNOSIS • RUL posterior pulmonary nodule, 2.3 cm \n\nPOSTOPERATIVE DIAGNOSIS • RUL posterior pulmonary nodule, 2.3 cm  • Status post Microwave Ablation (MWA)\n\nPROCEDURE • Electromagnetic Navigation Bronchoscopy (SuperDimension) to RUL target • Radial EBUS (rEBUS) localization • Cone-beam CT imaging with trajectory adjustment and confirmation  • Microwave Ablation of RUL target\n\nATTENDING [Name] ASSISTANT [Fellow name] SUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA [General anesthesia / airway type] \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an independent trained observer throughout the procedure. \n\nINSTRUMENTATION SuperDimension navigation system; Emprint 2.0 probe; rEBUS probe; cone-beam CT system. \n\nESTIMATED BLOOD LOSS Minimal \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and laterality. Relevant procedural images were saved to the medical record. \n\nElectromagnetic Navigation Bronchoscopy — RUL Nodule A CT-based navigation plan was loaded and registration was completed using the SuperDimension system.  The navigation catheter was advanced to the planned RUL target in the RB1 segment.\n\n• Initial rEBUS assessment: The radial EBUS probe was advanced. • Cone-beam CT imaging: A 3D spin was obtained to evaluate catheter-to-target alignment. • Confirmation: Cone-beam CT and radial EBUS confirmed the tool position within the lesion. \n\nMicrowave Ablation The Emprint 2.0 probe was advanced to the target. • Settings: Ablation was performed at 65 Watts for 5 minutes. • Parameters: Maximum temperature recorded was 85°C. • Post-Ablation Assessment: Repeat radial EBUS demonstrated a hyperechoic zone consistent with necrosis.\n\nHemostasis was confirmed. Final airway inspection demonstrated no clinically significant bleeding. No immediate complications occurred. \n\nIMPRESSION / PLAN • RUL posterior nodule (2.3 cm) successfully navigated to RB1. • Confirmed tool-in-lesion with radial EBUS and Cone-beam CT.  • Successful Microwave Ablation performed (65W x 5 min) with rEBUS confirmation of tissue necrosis. • Post-procedure monitoring per protocol; obtain post-procedure chest imaging to assess for PTX per local workflow."
  },
  {
    "id": "example_2",
    "input_text": "Indication: ILD (UIP/NSIP).\nTechnique: LMA, Flex Bronch, Radial EBUS.\n- RLL Basilar segments cleared via REBUS.\n- 1.9mm Cryoprobe.\n- Site 1: RLL Posterior Basal (5s freeze).\n- Site 2: RLL Lateral Basal (5s freeze).\n- Fogarty balloon used prophylactically.\n- 2 samples (10mm each).\n- No pneumothorax.",
    "ideal_output": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name]\n\nINDICATION FOR OPERATION [Patient Name] presents with Interstitial Lung Disease (suspected UIP/NSIP) requiring histopathologic diagnosis. \n\nCONSENT The nature, purpose, risks, benefits, and alternatives to bronchoscopy and cryobiopsy were discussed with the patient in detail. The patient wished to proceed and informed consent was obtained. \n\nPREOPERATIVE DIAGNOSIS\n\nInterstitial Lung Disease (UIP/NSIP) \n\nPOSTOPERATIVE DIAGNOSIS\n\nInterstitial Lung Disease\n\nSuccessful Transbronchial Cryobiopsy (RLL) \n\nPROCEDURE\n\nFlexible Bronchoscopy\n\nRadial EBUS (rEBUS) survey\n\nTransbronchial Cryobiopsy (RLL)\n\nProphylactic Fogarty Balloon placement \n\nATTENDING [Name]\n\nASSISTANT [Name]\n\nANESTHESIA General Anesthesia via Laryngeal Mask Airway (LMA) \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored throughout the procedure. \n\nESTIMATED BLOOD LOSS Minimal \n\nCOMPLICATIONS None; No pneumothorax noted. \n\nPROCEDURE IN DETAIL After induction of anesthesia and placement of the LMA, a timeout was performed confirming patient identity and planned procedure. \n\nAirway Inspection The bronchoscope was introduced through the LMA. A systematic airway inspection was performed, noting normal anatomy without endobronchial lesions.\n\nRadial EBUS & Preparation Attention was turned to the Right Lower Lobe (RLL).\n\nrEBUS Survey: A radial EBUS probe was advanced to the basilar segments. The survey confirmed the absence of significant vessels at the selected biopsy sites and allowed for navigation to the periphery. \n\n\nBalloon Block: A Fogarty balloon was positioned prophylactically at the lobar/segmental orifice to provide immediate tamponade if necessary. \n\nTransbronchial Cryobiopsy A 1.9mm cryoprobe was utilized for sampling. \n\nSite 1 (RLL Posterior Basal): The probe was advanced to the target. A 5-second freeze cycle was applied. The probe and scope were withdrawn en bloc.\n\nSite 2 (RLL Lateral Basal): The probe was advanced to the target. A 5-second freeze cycle was applied. The probe and scope were withdrawn en bloc.\n\nFindings & Hemostasis\n\n\nYield: A total of 2 samples were collected, measuring approximately 10mm each. \n\nHemostasis: The prophylactic Fogarty balloon was utilized/monitored. Final airway inspection demonstrated no clinically significant bleeding. \n\n\nPneumothorax Check: Post-procedure assessment demonstrated no pneumothorax. \n\nSPECIMENS\n\nRLL Transbronchial Cryobiopsy (2 samples) — Histology \n\nIMPRESSION / PLAN\n\nSuccessful transbronchial cryobiopsy of RLL basilar segments (Posterior and Lateral) for ILD evaluation. \n\nNo pneumothorax or significant bleeding complications. \n\nRecover per protocol; obtain post-procedure chest imaging to assess for late pneumothorax per local workflow."
  },
  {
    "id": "example_3",
    "input_text": "Procedure: Thoracoscopic exploration with pleurodesis.\nAction: The pleural space was accessed. Hemorrhagic fluid was evacuated. Nodular pathology on the parietal surface was sampled. A sclerosing agent (talc) was insufflated. A drainage catheter was sited.\nResult: Tissue obtained; symphysis attempted.",
    "ideal_output": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name] \n\nINDICATION FOR OPERATION [Patient Name] is a [Age]-year-old [Sex] who presents with [pleural effusion/nodules] requiring thoracoscopic diagnosis and management. \n\nCONSENT Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient or surrogate. Consent was signed and witnessed by an assisting medical professional. \n\nPREOPERATIVE DIAGNOSIS • Pleural effusion • Suspected pleural malignancy/nodules \n\nPOSTOPERATIVE DIAGNOSIS • Pleural effusion (hemorrhagic) • Parietal pleural nodules (biopsied) • Pleurodesis performed \n\nPROCEDURE • Medical Thoracoscopy (Pleuroscopy) • Thoracoscopic pleural biopsy • Talc pleurodesis (insufflation) • Indwelling drainage catheter/Chest tube placement \n\nATTENDING [Name] \n\nASSISTANT [Fellow name] \n\nSUPPORT STAFF RN: [Name] RT: [Name] \n\nANESTHESIA [General anesthesia / Deep sedation] \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an independent trained observer throughout the procedure. \n\nESTIMATED BLOOD LOSS Minimal \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL\n\nAfter induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and laterality. Relevant procedural images were saved to the medical record. \n\nMedical Thoracoscopy with Pleurodesis The pleural space was accessed. Thoracoscopic survey performed. Initial thoracoscopic survey demonstrates hemorrhagic fluid, which was evacuated. \n\nBiopsy: Nodular pathology on the parietal surface was identified. Biopsies taken. \n\nPleurodesis: A sclerosing agent (talc) was insufflated. Pleurodesis performed as indicated. \n\nDrainage: A drainage catheter was sited. Chest tube left in situ. \n\nThe patient tolerated the procedure well without immediate complications. \n\nSPECIMENS • Pleural fluid – cytology/culture • Parietal pleural biopsies – histology \n\nIMPRESSION / PLAN • Thoracoscopic exploration completed; hemorrhagic fluid evacuated. • Tissue obtained from parietal nodules. • Symphysis attempted via talc insufflation. • Drainage catheter sited. • Await final pathology and cytology. • Post-procedure monitoring per protocol; obtain post-procedure chest imaging."
  },
  {
    "id": "example_4",
    "input_text": "Thyroid cancer with tracheal compression. Pre-procedure obstruction approximately 83% Bronchus intermedius. Under general anesthesia with jet ventilation, rigid bronchoscopy performed. APC used for tumor ablation prior to stent placement. Airway measured and Ultraflex SEMS - Covered stent (20x40mm) deployed in Bronchus intermedius. Stent position confirmed with good expansion and patency. Post-procedure obstruction approximately 24%. No complications.",
    "ideal_output": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name]\n\nINDICATION FOR OPERATION [Patient Name] is a [Age]-year-old [Sex] with a history of thyroid cancer who presents with airway obstruction requiring intervention. The specific indication is an obstruction of the Bronchus intermedius estimated at 83%.\n\nCONSENT Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient or surrogate. The patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\n\nThyroid cancer with airway compression\n\nBronchus intermedius obstruction (approx. 83%)\n\nPOSTOPERATIVE DIAGNOSIS\n\nThyroid cancer with airway compression\n\nBronchus intermedius obstruction reduced to approx. 24% following intervention\n\nPROCEDURE\n\nRigid Bronchoscopy (Therapeutic)\n\nEndobronchial Tumor Destruction (APC)\n\nAirway Stent Placement (Ultraflex SEMS)\n\nATTENDING [Name]\n\nASSISTANT [Fellow name]\n\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General anesthesia with High-frequency jet ventilation.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an independent trained observer throughout the procedure.\n\nESTIMATED BLOOD LOSS Minimal \n\nCOMPLICATIONS None\n\nPROCEDURE IN DETAIL After induction of general anesthesia, a timeout was performed confirming patient identity, planned procedures, and laterality.\n\nRigid Bronchoscopy A rigid bronchoscope was introduced via the mouth under direct visualization. High-frequency jet ventilation (HFJV) was utilized. A complete airway survey was performed. The Bronchus intermedius was identified as the target area, with a pre-procedure obstruction noted at approximately 83%.\n\nEndobronchial Tumor Destruction Endobronchial obstruction was treated with Argon Plasma Coagulation (APC) for tumor ablation prior to stent placement. Performed at the Bronchus intermedius.\n\nAirway Stent Placement The airway was measured to determine appropriate stent sizing. A stent was deployed across the target stenosis under bronchoscopic guidance.\n\nStent Type: Ultraflex SEMS - Covered\n\nDimensions: 20mm x 40mm\n\nLocation: Bronchus intermedius\n\nFindings and Outcome Stent position was confirmed with good expansion and patency. Post-procedure obstruction was estimated at approximately 24%. Hemostasis was confirmed. The bronchoscope and adjunct instruments were withdrawn. The patient tolerated the procedure well without immediate complications.\n\nIMPRESSION / PLAN\n\nSuccessful rigid bronchoscopy with APC ablation and placement of a 20x40mm Covered Ultraflex SEMS in the Bronchus intermedius.\n\nAirway patency improved; obstruction reduced from 83% to 24%.\n\nPost-procedure monitoring per protocol."
  },
  {
    "id": "example_5",
    "input_text": "Indication: BI malignancy, pneumonia.\nAnesthesia: GA, ETT.\nFindings: BI 80% obstructed.\nProcedure: 6F catheter placed past tumor. Fluoro confirm. Dummy check.\nPlan: 6Gy x 4 weekly. Admit/Obs.",
    "ideal_output": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Referred Physician Name]\n\nINDICATION FOR OPERATION The patient presents with a Bronchus Intermedius (BI) malignancy and pneumonia requiring therapeutic intervention.\n\nCONSENT Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient or surrogate. The patient wished to proceed and informed consent was obtained. Consent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\n\nBronchus Intermedius malignancy \n\nPneumonia \n\nPOSTOPERATIVE DIAGNOSIS\n\nBronchus Intermedius malignancy (80% obstruction) \n\nCatheter placement for Brachytherapy \n\nPROCEDURE\n\nFlexible Bronchoscopy\n\nEndobronchial catheter placement (6 French)\n\nFluoroscopic guidance and confirmation \n\nDummy wire check\n\nATTENDING [Name] \n\nASSISTANT [Name] \n\nSUPPORT STAFF RN: [Name] RT: [Name] \n\nANESTHESIA General anesthesia / Endotracheal intubation (ETT).\n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an independent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible bronchoscope; 6 French catheter; Fluoroscopy C-arm.\n\nESTIMATED BLOOD LOSS Minimal \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and laterality. Relevant procedural images were saved to the medical record.\n\nAirway Inspection The bronchoscope was passed via the ETT into the trachea. A systematic inspection was performed.\n\nFindings: The Bronchus Intermedius (BI) was identified and noted to be 80% obstructed by malignant tumor burden.\n\nCatheter Placement Under bronchoscopic and fluoroscopic guidance, a 6 French catheter was introduced.\n\nThe catheter was successfully navigated and placed past the tumor obstruction in the Bronchus Intermedius.\n\n\nConfirmation: Fluoroscopy was utilized to confirm the final position of the catheter.\n\nDummy Check: A dummy check wire was inserted into the catheter to ensure patency and lack of kinking. The wire passed without difficulty.\n\nFinal Assessment The bronchoscope was withdrawn. The patient tolerated the procedure well without immediate complications.\n\nIMPRESSION / PLAN\n\nBronchus Intermedius malignancy with 80% obstruction.\n\nSuccessful placement of 6F catheter past the tumor with fluoroscopic confirmation and successful dummy check.\n\nPlan: Proceed with High-Dose Rate (HDR) Brachytherapy: 6Gy x 4 weekly fractions.\n\nAdmit to hospital for observation."
  },
  {
    "id": "example_6",
    "input_text": "Indication: 9mm RLL nodule.\nSystem: Galaxy.\nVerif: Fluoro + rEBUS (Concentric).\nAction: TBNA x4, Bx x6, Brush, BAL (RB10).\nROSE: Negative.",
    "ideal_output": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name] INDICATION FOR OPERATION [Patient Name] is a [Age]-year-old [Sex] who presents with a 9 mm RLL pulmonary nodule requiring bronchoscopic diagnosis. \n\nCONSENT Obtained before the procedure. Risks, benefits, and alternatives were discussed. \n\nPREOPERATIVE DIAGNOSIS\n\nRLL pulmonary nodule, 9 mm \n\nPOSTOPERATIVE DIAGNOSIS\n\nRLL pulmonary nodule, 9 mm \n\nROSE negative (final pathology pending) \n\nPROCEDURE\n\nRobotic navigational bronchoscopy (Galaxy) to RLL target \n\nrEBUS localization (Concentric) \n\nFluoroscopy with trajectory adjustment and confirmation \n\nTBNA of RLL target (4 passes) \n\nTransbronchial biopsy of RLL target (6 samples) \n\nBronchial Brush \n\nBronchoalveolar Lavage (RB10) \n\nPROCEDURE IN DETAIL After induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and laterality. \n\nRobotic Navigational Bronchoscopy (Galaxy) — RLL Nodule Robotic navigation bronchoscopy was performed using the Galaxy system. A navigation plan from the pre-procedure CT was loaded and registration completed. The robotic catheter was advanced to the planned RLL target (9 mm) under navigational guidance. \n\nVerification and Target Confirmation\n\n\nRadial EBUS: A concentric ultrasound pattern was obtained to confirm lesion location. \n\n\nFluoroscopy: Fluoroscopic imaging was used to confirm catheter-to-target alignment. \n\nRLL Target Sampling\n\n\nTBNA: Transbronchial needle aspiration was performed. A total of 4 passes were obtained from the RLL target. \n\n\nBiopsy: Transbronchial forceps biopsies were performed with a total of 6 samples collected. \n\n\nBrush: Endobronchial/transbronchial brushings were obtained and submitted. \n\nBAL: Bronchoalveolar lavage was performed in the RB10 with saline instilled and returned. Specimens were submitted. \n\n\nROSE: Preliminary ROSE cytology was reported as negative (final results are pending). \n\nHemostasis was confirmed after sampling. The patient tolerated the procedure well without immediate complications. \n\nSPECIMENS\n\nRLL nodule TBNA (4 passes) — cytology \n\nRLL transbronchial biopsy (6 samples) — histology \n\nRLL Bronchial Brush — cytology \n\nRB10 BAL — microbiology/cytology \n\nIMPRESSION / PLAN\n\nRLL nodule successfully sampled with fluoroscopic confirmation and concentric rEBUS pattern. \n\nROSE negative for malignancy. \n\nAwait final pathology and cytology. \n\nPost-procedure monitoring per protocol; obtain post-procedure chest imaging to assess for PTX per local workflow."
  },
  {
    "id": "example_7",
    "input_text": "Procedure: Robotic Bronchoscopy LLL.\nTarget: 20mm nodule.\nActions: Navigated to LB7+8. Locked sheath. rEBUS adjacent.\nSampling: 19G TBNA x7. Forceps biopsy x6. BAL performed.\nROSE: Negative for malignancy.\nIssues: None.",
    "ideal_output": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\n\nCC Referred Physician: [Name / Self, Referred] \n\nINDICATION FOR OPERATION [Patient Name] is a [Age]-year-old [Sex] who presents with a 20mm LLL pulmonary nodule requiring bronchoscopic diagnosis. The nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail. The patient wished to proceed and informed consent was obtained. \n\nCONSENT Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient or surrogate. Consent was signed and witnessed by an assisting medical professional. \n\nPREOPERATIVE DIAGNOSIS\n\nLLL pulmonary nodule, 20mm \n\n[Additional ICD-10 if applicable]\n\nPOSTOPERATIVE DIAGNOSIS\n\nLLL pulmonary nodule, 20mm \n\nROSE negative for malignancy (final pathology pending) \n\nPROCEDURE\n\nRobotic navigational bronchoscopy (Ion) to LLL target \n\nrEBUS localization \n\nTBNA of LLL target with 19-gauge needle (7 passes) \n\nTransbronchial forceps biopsy of LLL target (6 samples) \n\nBronchoalveolar Lavage (BAL) \n\nRapid On-Site Evaluation (ROSE) \n\nATTENDING [Name] \n\nASSISTANT [Fellow name] \n\nSUPPORT STAFF RN: [Name] RT: [Name] \n\nANESTHESIA [General anesthesia / airway type] \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an independent trained observer throughout the procedure. \n\nINSTRUMENTATION Ion robotic bronchoscopy platform; rEBUS probe; 19G TBNA needle; biopsy forceps; bronchoscope. \n\nESTIMATED BLOOD LOSS Minimal \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and laterality. Relevant procedural images were saved to the medical record. Patient position: [Supine] \n\nRobotic Navigational Bronchoscopy (Ion) — LLL Nodule A CT-based navigation plan was loaded and robotic registration was completed. The robotic catheter was advanced to the planned LLL target (20mm) in the LB7+8 segment. \n\nInitial rEBUS assessment: The sheath was locked. Radial EBUS confirmed an adjacent ultrasound pattern regarding the lesion. \n\nLLL Target Sampling\n\nTBNA: 19-gauge needle used; 7 passes obtained from the LLL target. \n\n\nForceps Biopsy: 6 transbronchial forceps biopsy samples obtained from the LLL target. \n\nBAL: Bronchoalveolar lavage was performed in the LLL with saline instilled and returned. Specimens were submitted. \n\n\nROSE (LLL target): No malignant cells identified on ROSE (final cytology/histology pending). \n\nHemostasis was confirmed after sampling. Final airway inspection demonstrated no clinically significant bleeding. No immediate complications occurred. \n\nSPECIMENS\n\nLLL nodule TBNA (7 passes) — cytology \n\nLLL transbronchial biopsy (6 samples) — histology \n\nLLL BAL — microbiology/cytology \n\nIMPRESSION / PLAN\n\nLLL nodule (20mm) successfully sampled via robotic bronchoscopy. \n\nNavigated to LB7+8 with adjacent rEBUS signal. \n\nROSE negative for malignancy. \n\nAwait final pathology and cytology. \n\nPost-procedure monitoring per protocol; obtain post-procedure chest imaging to assess for PTX per local workflow."
  },
  {
    "id": "example_8",
    "input_text": "Indication: Recurrent L effusion (Hepatic hydrothorax).\nProc: Thoracentesis w/ catheter.\n- 12Fr pigtail.\n- No imaging.\n- Drained 2100mL clear yellow.\n- Catheter removed.",
    "ideal_output": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date]\n\n\nCC Referred Physician: [Name] \n\nINDICATION FOR OPERATION The patient presents with a recurrent left pleural effusion (hepatic hydrothorax). \n\nCONSENT Obtained before the procedure. The nature, purpose, risks, benefits, and alternatives to the procedure were discussed with the patient in detail. The patient wished to proceed and informed consent was obtained. \n\nPREOPERATIVE DIAGNOSIS\n\nRecurrent left pleural effusion (hepatic hydrothorax) \n\nPOSTOPERATIVE DIAGNOSIS\n\nRecurrent left pleural effusion (hepatic hydrothorax) \n\nSuccessful drainage of 2100 mL clear yellow fluid \n\nPROCEDURE\n\nLeft-sided Thoracentesis via 12Fr Pigtail Catheter \n\nATTENDING [Name] \n\nSUPPORT STAFF RN: [Name] RT: [Name] \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an independent trained observer throughout the procedure. \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL\n\nAfter the successful induction of anesthesia, a timeout was performed confirming the patient's name, procedure type, and laterality. \n\nPigtail Catheter Placement (Modified for Drainage) The insertion site was prepped and draped in sterile fashion. Anesthesia: Lidocaine 1% was used for local anesthesia. Entry Site: Left hemithorax. \n\nFindings and Technique: A 12Fr pigtail catheter was utilized. A pigtail catheter was inserted using the Seldinger technique. Entry into the pleural space was confirmed with the easy removal of pleural fluid. A guidewire was inserted using the introducer needle. The introducer needle was then removed. A dilator was then inserted over the wire with a twisting motion in order to form a tract for catheter insertion. The dilator was removed and the pigtail catheter (with trocar) was advanced over the guidewire. \n\n\nImaging: No imaging was utilized for this procedure (anatomic landmarks only). \n\nDrainage:\n\n\nFluid Removed: 2100 mL \n\n\nAppearance: Clear yellow \n\nFollowing adequate drainage, the pigtail catheter was removed. The site was dressed with occlusive gauze. \n\nIMPRESSION / PLAN\n\nRecurrent left pleural effusion successfully drained via pigtail catheter. \n\nTotal of 2100 mL clear yellow fluid removed. \n\nCatheter removed at the end of the procedure. \n\nPost-procedure monitoring per protocol."
  },
  {
    "id": "example_9",
    "input_text": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nPatient: [REDACTED]\nMedical Record: [REDACTED]\nService Date: [REDACTED]\nOperator: Steven Park, MD\n\nCLINICAL RATIONALE\nCombined staging and peripheral nodule diagnosis. Target lesion: 27.5mm ground-glass nodule localized to RLL superior (B6).\n\nSEDATION DETAILS\nGeneral endotracheal sedation administered. 8.0mm airway device deployed orally.\n\nOPERATIVE NARRATIVE\n\nSEGMENT 1: LINEAR EBUS MEDIASTINAL ASSESSMENT\n\nThe convex-probe ultrasound bronchoscope (Fujifilm EB-580S) was advanced through the endotracheal conduit. Systematic mediastinal survey was executed. Lymph nodes were visualized at multiple stations and sampled utilizing 22-gauge aspiration needle (Acquire).\n\nStation 11R: Visualized homogeneous node (22.0x13.6mm). Executed 2 aspiration passes. ROSE yielded: Malignant - small cell carcinoma.\nStation 4R: Visualized heterogeneous node (13.7x29.3mm). Executed 4 aspiration passes. ROSE yielded: Atypical cells.\nStation 11L: Visualized homogeneous node (18.9x31.0mm). Executed 3 aspiration passes. ROSE yielded: Malignant - small cell carcinoma.\n\nSEGMENT 2: ROBOTIC-ASSISTED PERIPHERAL NAVIGATION\n\nThe Galaxy robotic navigation platform (Noah Medical) was initialized and calibrated. Registration accuracy measured 2.8mm. The articulating catheter was maneuvered to the RLL superior (B6) target zone.\n\nRadial ultrasound miniprobe was deployed, yielding eccentric visualization of the lesion. Instrument-within-target was verified via cbct.\n\nTISSUE ACQUISITION:\n- Grasping forceps specimens acquired: 4\n- Aspiration needle passes executed: 3  \n- Cytology brushings harvested: 2\n- Lavage fluid extracted from RLL\n\nROSE assessment yielded: Adequate lymphocytes, no malignancy\n\nSPECIMEN DISPOSITION\n- EBUS aspirates dispatched to: Cytology, cell block, flow cytometry\n- Parenchymal samples dispatched to: Surgical pathology, molecular analysis\n- Brushings dispatched to: Cytology\n- Lavage dispatched to: Microbiology (bacterial, mycobacterial, fungal)\n\nOUTCOME ASSESSMENT\nProcedure concluded without adverse events. Hemorrhage: negligible (<10mL). Post-procedure radiograph: unremarkable, pneumothorax excluded.\n\nDISPOSITION\nPatient [REDACTED] recovery suite. Discharged to residence following observation period. Outpatient follow-up scheduled for pathology review.\n\nSUMMARY\n1. EBUS-guided mediastinal staging successfully executed (3 stations sampled)\n2. Robotic navigation to peripheral target successfully accomplished\n3. Tissue acquisition achieved via multiple modalities\n4. Zero procedural complications documented\n\nElectronically attested,\n[REDACTED], MD\nDivision of Interventional Pulmonology\nBaptist Medical Center",
    "ideal_output": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\n\nDATE OF PROCEDURE: [Date]  OPERATOR: Steven Park, MD CC Referred Physician: [Name] \n\nINDICATION FOR OPERATION The patient presents with a 27.5mm ground-glass nodule localized to RLL superior (B6). The nature, purpose, risks, benefits and alternatives to Bronchoscopy were discussed with the patient in detail. The patient wished to proceed and informed consent was obtained. \n\nCONSENT Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient or surrogate. Consent was signed and witnessed by an assisting medical professional. \n\nPREOPERATIVE DIAGNOSIS\n\nRLL pulmonary nodule, 27.5 mm (Ground-glass) \n\nMediastinal lymphadenopathy \n\nPOSTOPERATIVE DIAGNOSIS\n\nRLL pulmonary nodule, 27.5 mm \n\nEBUS staging performed; Malignant (Small Cell) at stations 11R and 11L \n\nPROCEDURE\n\nEBUS-TBNA staging (Stations 11R, 4R, 11L) with ROSE \n\nRobotic navigational bronchoscopy (Galaxy) to RLL target \n\nCone-beam CT imaging with trajectory adjustment and confirmation \n\nRadial EBUS localization \n\nTransbronchial biopsy/Forceps of RLL target (4 samples) \n\nTBNA of RLL target (3 passes) \n\nBronchial Brushings (2 samples) \n\nBronchial Washing \n\nANESTHESIA General endotracheal sedation administered. \n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure. \n\nESTIMATED BLOOD LOSS Minimal (<10mL) \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After the successful induction of anesthesia, a timeout was performed (confirming the patient's name, procedure type, and procedure location).  An 8.0mm airway device was deployed orally.\n\nEBUS STAGING The endobronchial ultrasound-capable bronchoscope (Fujifilm EB-580S) was introduced and the following lymph node station(s) were identified: \n\nStation 11R:\n\nSize: 22.0 x 13.6 mm (Homogeneous) \n\nBiopsy Tools: 22-gauge aspiration needle (Acquire) \n\nPasses: 2 \n\nROSE Results: Malignant - small cell carcinoma \n\nStation 4R:\n\nSize: 13.7 x 29.3 mm (Heterogeneous) \n\nBiopsy Tools: 22-gauge aspiration needle (Acquire) \n\nPasses: 4 \n\nROSE Results: Atypical cells \n\nStation 11L:\n\nSize: 18.9 x 31.0 mm (Homogeneous) \n\nBiopsy Tools: 22-gauge aspiration needle (Acquire) \n\nPasses: 3 \n\nROSE Results: Malignant - small cell carcinoma \n\nRobotic Navigational Bronchoscopy (Galaxy) — RLL Nodule Robotic navigation bronchoscopy was performed using the Galaxy robotic navigation platform (Noah Medical). Registration was completed; the navigation catheter was advanced.  Registration accuracy measured 2.8mm. The articulating catheter was maneuvered to the RLL superior (B6) target zone.\n\n\nRadial EBUS: Radial ultrasound miniprobe was deployed, yielding eccentric visualization of the lesion. \n\n\nCone-beam CT imaging: Tool-in-lesion was confirmed by CBCT. \n\nRLL Target Sampling Sampling was obtained through the extended working channel as detailed: \n\n\nForceps: 4 specimens acquired. \n\n\nTBNA: 3 passes executed. \n\n\nBrush: 2 cytology brushings harvested. \n\n\nWashing: Lavage fluid extracted from RLL. \n\n\nROSE (RLL target): Adequate lymphocytes, no malignancy. \n\nHemostasis was confirmed. The patient tolerated the procedure well without immediate complications. Post-procedure radiograph: unremarkable, pneumothorax excluded. \n\nSPECIMENS\n\nStation 11R, 4R, 11L EBUS aspirates — Cytology, cell block, flow cytometry \n\nRLL Parenchymal samples — Surgical pathology, molecular analysis \n\nRLL Brushings — Cytology \n\nRLL Lavage — Microbiology (bacterial, mycobacterial, fungal) \n\nIMPRESSION / PLAN\n\nEBUS-guided mediastinal staging successfully executed (3 stations sampled) with ROSE malignant (small cell) at stations 11R and 11L. \n\nRobotic navigation to peripheral target successfully accomplished with tissue acquisition achieved via multiple modalities. \n\nNo immediate complications occurred. \n\nDischarged to residence following observation period."
  },
  {
    "id": "example_10",
    "input_text": "Procedure: EBUS-TBNA.\nIndication: Mediastinal staging.\nNodes Sampled:\n- 4R (18mm): Positive for Adeno.\n- 7 (22mm): Positive for Adeno.\n- 10R (14mm): Positive for Adeno.\nTechnique: 22G needle, 3-4 passes per station.\nResult: N3 disease (Contralateral/Supraclavicular not sampled, but extensive N2 involved).",
    "ideal_output": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT \n\nDATE OF PROCEDURE: [Date] INDICATION FOR OPERATION Mediastinal staging.\n\nPREOPERATIVE DIAGNOSIS Mediastinal Adenopathy POSTOPERATIVE DIAGNOSIS N3 disease (Adenocarcinoma)\n\nPROCEDURE\n\nEndobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA) (Stations 4R, 7, 10R) \n\nPROCEDURE IN DETAIL After the successful induction of anesthesia, a timeout was performed confirming the patient's identity and planned procedure.  The patient was monitored continuously throughout the procedure.\n\nEBUS-TBNA Staging The endobronchial ultrasound-capable bronchoscope was introduced and a systematic mediastinal and hilar survey was performed. The following lymph node stations were identified and sampled based on ultrasound criteria using a 22-gauge needle: \n\nStation 4R (Right Lower Paratracheal): The node measured 18 mm by EBUS. 3-4 passes were performed. \n\nResult: Positive for Adenocarcinoma.\n\nStation 7 (Subcarinal): The node measured 22 mm by EBUS. 3-4 passes were performed. \n\nResult: Positive for Adenocarcinoma.\n\nStation 10R (Right Hilar): The node measured 14 mm by EBUS. 3-4 passes were performed. \n\nResult: Positive for Adenocarcinoma.\n\nPrior to withdrawal of the bronchoscope, inspection demonstrated no evidence of bleeding.  The patient tolerated the procedure well. There were no immediate complications. \n\nIMPRESSION / PLAN\n\nEBUS-TBNA performed for mediastinal staging. \n\nSamples obtained from stations 4R, 7, and 10R were positive for Adenocarcinoma.\n\nFindings consistent with N3 disease."
  },
  {
    "id": "example_11",
    "input_text": "\"Dx: Lung-RADS 4X, 22mm LUL.\nMethod: Galaxy Robot + TiLT+.\nFindings: 1.5cm divergence on TiLT. Corrected.\nrEBUS: Eccentric.\n intervention: TBNA x5, Forceps x7, Brush, Fiducial.\nROSE: Lymphocytes/benign.\",",
    "ideal_output": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name]\n\nINDICATION FOR OPERATION [Patient Name] is a patient who presents with a 22 mm LUL (Lung-RADS 4X) pulmonary nodule requiring bronchoscopic diagnosis and staging. The nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail. The patient wished to proceed and informed consent was obtained.\n\nCONSENT Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient or surrogate. Consent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\n\nLUL pulmonary nodule, 22 mm (Lung-RADS 4X) \n\nPOSTOPERATIVE DIAGNOSIS\n\nLUL pulmonary nodule, 22 mm\n\nROSE: Lymphocytes/benign (final pathology pending) \n\nPROCEDURE\n\nRobotic navigational bronchoscopy (Galaxy) to LUL target\n\nTiLT+ (Tomosynthesis-based Tool-in-Lesion Tomography) with trajectory adjustment\n\nRadial EBUS (rEBUS) localization\n\nTransbronchial needle aspiration (TBNA) of LUL target (5 passes)\n\nTransbronchial forceps biopsy of LUL target (7 samples)\n\nBronchial brushings\n\nFiducial marker placement\n\nATTENDING [Name]\n\nASSISTANT [Name]\n\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General anesthesia\n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an independent trained observer throughout the procedure.\n\nINSTRUMENTATION Galaxy robotic bronchoscopy platform; TiLT+ imaging; rEBUS probe; TBNA needles; biopsy forceps; bronchial brush; fiducial markers.\n\nESTIMATED BLOOD LOSS Minimal \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and laterality. Relevant procedural images were saved to the medical record.\n\nRobotic Navigational Bronchoscopy (Galaxy) — LUL Nodule A CT-based navigation plan was loaded and robotic registration was completed. The Galaxy robotic catheter was advanced to the planned LUL target (22 mm).\n\nImaging & Divergence Correction (TiLT+): A TiLT+ spin was obtained intra-procedurally to evaluate catheter-to-target alignment.\n\nFindings: A 1.5 cm divergence was identified between the virtual target and the actual lesion location.\n\nCorrection: Registration correction was applied to the catheter path. The trajectory was adjusted based on the reconstruction/overlay, and a confirmatory spin verified corrected alignment.\n\nrEBUS Assessment: A radial EBUS probe was advanced. An eccentric ultrasound pattern was obtained, confirming the lesion location relative to the airway.\n\nLUL Target Sampling\n\nTBNA: Transbronchial needle aspiration was performed; 5 passes were obtained from the LUL target.\n\nForceps Biopsy: Transbronchial forceps biopsies were performed with a total of 7 samples collected.\n\nBrush: Endobronchial/transbronchial brushings were obtained and submitted.\n\nFiducial Placement: A fiducial marker was placed at the targeted airway location under guidance.\n\n\nROSE (LUL target): Preliminary evaluation showed lymphocytes/benign cells (final cytology/histology pending).\n\nHemostasis was confirmed after sampling. The bronchoscope was withdrawn. The patient tolerated the procedure well without immediate complications.\n\nSPECIMENS\n\nLUL nodule TBNA (5 passes) — cytology\n\nLUL forceps biopsy (7 samples) — histology\n\nLUL brush — cytology\n\nIMPRESSION / PLAN\n\nLUL nodule (22 mm) successfully sampled using Galaxy robotic bronchoscopy.\n\nDivergence of 1.5 cm identified and corrected using TiLT+ imaging.\n\nLesion confirmed with eccentric rEBUS pattern.\n\nFiducial marker placed.\n\nROSE favored benign process (lymphocytes); await final pathology and cytology.\n\nPost-procedure monitoring per protocol."
  },
  {
    "id": "example_12",
    "input_text": "77yo F Dx: Lung Cancer Staging, Proc: EBUS-TBNA + Robotic Bronch (Galaxy), GA/ETT, Linear EBUS: Olympus BF-UC180F, Stations: 11R (4x), 2L (2x), 4L (4x), Nav to LLL lateral basal (B9), rEBUS: Eccentric view, TIL confirmed: Radial EBUS, Bx x7, TBNA x2, ROSE+: Suspicious for malignancy, Complications: None, EBL: <10mL Dispo: Home",
    "ideal_output": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION The patient is a 77-year-old female who presents with a lung nodule requiring bronchoscopic diagnosis and lung cancer staging. The nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail. The patient wished to proceed and informed consent was obtained. \n\nCONSENT Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient or surrogate. Consent was signed and witnessed by an assisting medical professional. \n\nPREOPERATIVE DIAGNOSIS\n\nLung Nodule (LLL lateral basal)\n\nLung Cancer Staging\n\nPOSTOPERATIVE DIAGNOSIS\n\nLLL lateral basal (B9) pulmonary nodule\n\nEBUS staging performed;\n\nROSE suspicious for malignancy \n\nPROCEDURE\n\nRobotic navigational bronchoscopy (Galaxy) to LLL target \n\nRadial EBUS (rEBUS) localization and confirmation\n\nTransbronchial biopsy of LLL target (7 samples) \n\nTBNA of LLL target (2 passes)\n\nEBUS-TBNA staging (Stations 11R, 2L, 4L)\n\nATTENDING [Name]\n\nASSISTANT [Name]\n\nANESTHESIA General anesthesia / Endotracheal tube (ETT) \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an independent trained observer throughout the procedure. \n\nINSTRUMENTATION Galaxy robotic bronchoscopy platform; Olympus BF-UC180F Linear EBUS scope; rEBUS probe; TBNA needles; biopsy forceps. \n\nESTIMATED BLOOD LOSS < 10 mL \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and laterality. Relevant procedural images were saved to the medical record. \n\nRobotic Navigational Bronchoscopy (Galaxy) — LLL Nodule A CT-based navigation plan was loaded and registration was completed. The robotic catheter was advanced to the planned LLL lateral basal (B9) target. \n\nLocalization: Radial EBUS was performed.\n\nTarget Confirmation: rEBUS demonstrated an eccentric view of the lesion. Tool-in-lesion (TIL) was confirmed via Radial EBUS. \n\nLLL Target Sampling Sampling was performed with the following acquisition:\n\nBiopsy: 7 forceps biopsies were obtained from the target.\n\n\nTBNA: 2 needle passes were obtained from the target. \n\n\nROSE: Preliminary on-site evaluation was positive (suspicious for malignancy). \n\nHemostasis was confirmed after sampling. \n\nEBUS STAGING The Galaxy catheter was removed. The Olympus BF-UC180F EBUS bronchoscope was introduced and a systematic mediastinal/hilar survey was performed. \n\nThe following lymph node stations were sampled:\n\nStation 11R: 4 passes\n\nStation 2L: 2 passes\n\nStation 4L: 4 passes\n\nFinal airway inspection demonstrated no clinically significant bleeding. No immediate complications occurred. \n\nSPECIMENS\n\nLLL lateral basal (B9) TBNA (2 passes) — cytology\n\nLLL lateral basal (B9) biopsy (7 samples) — histology\n\nStation 11R EBUS-TBNA (4 passes) — cytology\n\nStation 2L EBUS-TBNA (2 passes) — cytology\n\nStation 4L EBUS-TBNA (4 passes) — cytology\n\nIMPRESSION / PLAN\n\nLLL lateral basal (B9) nodule successfully sampled using Galaxy robotic navigation; rEBUS confirmed eccentric view and tool-in-lesion.\n\nROSE of the LLL target was suspicious for malignancy.\n\nEBUS staging performed at stations 11R, 2L, and 4L. \n\nAwait final pathology and cytology. \n\nPatient discharged home."
  },
  {
    "id": "example_13",
    "input_text": "Ind: Met lung CA, 62% LMS. Proc: Rigid bronch, Microdebrider, APC. Action: Excision + Ablation. Result: obstruction 62% -> 39%.EBL: 50mL. Plan: ICU.",
    "ideal_output": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION [Patient Name] is a patient with metastatic lung cancer who presents with a 62% obstruction of the Left Main Stem (LMS) bronchus requiring bronchoscopic intervention.\n\nCONSENT Obtained before the procedure. Indications (airway obstruction), potential complications, and alternatives were discussed with the patient or surrogate. The patient wished to proceed and informed consent was obtained.\n\nPREOPERATIVE DIAGNOSIS\n\nMetastatic lung cancer\n\nLeft Main Stem (LMS) bronchial obstruction (62%) \n\nPOSTOPERATIVE DIAGNOSIS\n\nMetastatic lung cancer\n\nLeft Main Stem (LMS) bronchial obstruction reduced to 39% \n\nPROCEDURE\n\nRigid Bronchoscopy (Therapeutic)\n\nMicrodebrider Debridement (Tumor Excision)\n\nArgon Plasma Coagulation (APC) Ablation\n\nComplex Airway Management \n\nATTENDING [Name]\n\nASSISTANT [Fellow name]\n\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an independent trained observer throughout the procedure.\n\nESTIMATED BLOOD LOSS 50 mL \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After induction of general anesthesia, a timeout was performed confirming patient identity, planned procedures, and laterality.\n\nRigid Bronchoscopy — Left Main Stem Recanalization A rigid bronchoscope was introduced via the mouth under direct visualization. A complete airway survey was performed.\n\nFindings: The Left Main Stem (LMS) bronchus was identified with a 62% obstruction caused by tumor ingrowth.\n\nTherapeutic Intervention The following therapeutic interventions were performed to address the obstruction:\n\nMicrodebrider Debridement: The endobronchial tumor was excised with mechanical debridement using a microdebrider to debulk the lesion.\n\nArgon Plasma Coagulation (APC): Endobronchial obstruction was treated with APC for tumor destruction and hemostasis.\n\nResults\n\nModality: Microdebrider and APC.\n\nPatency: Prior to treatment, the affected airway (LMS) was noted to be 62% obstructed. After treatment, the obstruction was reduced to 39%.\n\nHemostasis was confirmed. The bronchoscope and adjunct instruments were withdrawn. The patient tolerated the procedure well without immediate complications.\n\nIMPRESSION / PLAN\n\nSuccessful rigid bronchoscopy with microdebrider excision and APC ablation of LMS tumor.\n\nLMS obstruction reduced from 62% to 39%.\n\nHemostasis achieved with EBL of 50 mL.\n\n\nPlan: Admit to ICU for post-procedure monitoring."
  },
  {
    "id": "example_14",
    "input_text": "Indication: Post-PDT Debridement (48h). Procedure: Bronchoscopy, Debridement. Findings: LUL necrosis. 74% obstructed -> 5% post-debridement. Tools: Forceps, Rigid Coring, Cryoprobe. Specimen: None. Plan: Surveillance 6 wks.",
    "ideal_output": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name]\n\nINDICATION FOR OPERATION [Patient Name] is a [Age]-year-old [Sex] who presents for scheduled debridement 48 hours following Photodynamic Therapy (PDT). The nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail. The patient wished to proceed and informed consent was obtained. \n\nCONSENT Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient or surrogate. Consent was signed and witnessed by an assisting medical professional. \n\nPREOPERATIVE DIAGNOSIS\n\nLUL airway obstruction (Necrosis)\n\nStatus post-Photodynamic Therapy (PDT)\n\nPOSTOPERATIVE DIAGNOSIS\n\nLUL airway obstruction (Necrosis), successfully debrided\n\nStatus post-Photodynamic Therapy (PDT)\n\nPROCEDURE\n\nRigid Bronchoscopy\n\nMechanical Debridement (Forceps, Rigid Coring)\n\nEndobronchial Cryodebridement\n\nFinal airway inspection\n\nATTENDING [Name]\n\nASSISTANT [Fellow name]\n\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia\n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an independent trained observer throughout the procedure. \n\nINSTRUMENTATION Rigid bronchoscope; forceps; cryobiopsy probe; suction. \n\nESTIMATED BLOOD LOSS Minimal \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and laterality. Relevant procedural images were saved to the medical record. \n\nAirway Inspection and Debridement A rigid bronchoscope was introduced under direct visualization. A complete airway survey was performed. Attention was directed to the Left Upper Lobe (LUL), which showed significant necrosis consistent with the recent Photodynamic Therapy.\n\nDebridement A follow‑up bronchoscopy was performed to address the LUL necrosis. The necrotic tissue at the LUL was debrided using mechanical forceps, rigid coring, and a cryoprobe. The cryoprobe was applied to adherent secretions and necrotic tissue until adherence was achieved, and the probe was withdrawn.\n\nResults Prior to debridement, the affected airway was noted to be 74% obstructed. After treatment, the airway was 5% obstructed (95% patent). No active bleeding was seen after debridement. The patient tolerated the procedure well.\n\nSPECIMENS\n\nNone.\n\nIMPRESSION / PLAN\n\nSuccessful debridement of LUL necrosis post-PDT; airway patency improved from 74% obstruction to 5% residual obstruction.\n\nSurveillance bronchoscopy planned in 6 weeks.\n\nPost-procedure monitoring per protocol."
  },
  {
    "id": "example_15",
    "input_text": "60yo female here for bronch w EBUS staging and robotic biopsy of a 23.3mm RLL nodule that was solid on CT, bronchus sign was negative, no PET done..under general we did linear EBUS first using the Fujifilm EB-580S scope with 22g needle and sampled stations 2R x4, 10R x3, 2L x2, ROSE was there and showed Malignant - NSCLC NOS at multiple stations..then switched to Galaxy robot and navigated to the RLL medial basal (B7) lesion, registration was 1.9mm which is fine, got radial EBUS showing adjacent view and did tool in lesion confirmation with radial ebus. took 5 forceps bx, 4 needle passes, brushings x2, BAL sent for cultures..ROSE from the nodule was Adequate lymphocytes, no malignancy..no bleeding no ptx   patient did well.specimens to path for cyto, surgical path, cell block, flow, molecular if needed.d/c home after recovery with standard precautions, f/u 1-2wks for path",
    "ideal_output": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Referred Physician Name]\n\nINDICATION FOR OPERATION The patient is a 60-year-old female who presents with a 23.3 mm RLL nodule found to be solid on CT with a negative bronchus sign.  No PET scan was performed. The nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail. The patient wished to proceed and informed consent was obtained. \n\nPREOPERATIVE DIAGNOSIS\n\nRLL pulmonary nodule, 23.3 mm\n\nMediastinal/Hilar lymphadenopathy (suspected) \n\nPOSTOPERATIVE DIAGNOSIS\n\nRLL pulmonary nodule, 23.3 mm (ROSE benign/nondiagnostic)\n\nMediastinal/Hilar lymphadenopathy; ROSE Malignant - NSCLC NOS (final pathology pending) \n\nPROCEDURE\n\nLinear Endobronchial Ultrasound (EBUS) with Transbronchial Needle Aspiration (TBNA)\n\nRobotic navigational bronchoscopy (Galaxy) to RLL target \n\nRadial EBUS localization (adjacent view)\n\nTransbronchial biopsy of RLL target (5 forceps biopsies)\n\nTransbronchial needle aspiration of RLL target (4 passes)\n\nBronchial brushings (2 samples)\n\nBronchoalveolar lavage (BAL)\n\nANESTHESIA General anesthesia \n\nESTIMATED BLOOD LOSS Minimal \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and laterality. \n\nEBUS Staging The linear EBUS scope (Fujifilm EB-580S) was introduced and a systematic mediastinal/hilar survey was performed. Lymph node stations were sampled using a 22-gauge needle.\n\nStation 2R: Sampled 4 times.\n\nStation 10R: Sampled 3 times.\n\nStation 2L: Sampled 2 times. ROSE Results: On-site evaluation demonstrated Malignancy - NSCLC NOS at multiple stations.\n\nRobotic Navigational Bronchoscopy (Galaxy) — RLL Nodule Robotic navigation bronchoscopy was performed using the Galaxy system. A navigation plan was loaded and registration was completed with a registration error of 1.9 mm. The robotic catheter was advanced to the planned RLL medial basal (B7) target.\n\nRadial EBUS: Confirmed tool-in-lesion with an adjacent view.\n\nRLL Target Sampling\n\nForceps Biopsy: 5 biopsies were obtained.\n\nTBNA: 4 passes were obtained with a needle.\n\nBrushings: 2 samples collected.\n\nBAL: Lavage performed and sent for cultures.\n\n\nROSE (RLL target): Adequate lymphocytes, no malignancy identified on ROSE. \n\nFinal Assessment Hemostasis was confirmed after sampling.  Final airway inspection demonstrated no clinically significant bleeding. No immediate complications, including pneumothorax, occurred. \n\nSPECIMENS\n\nEBUS-TBNA (Stations 2R, 10R, 2L): Cytology, cell block, surgical pathology, flow cytometry, molecular.\n\nRLL Nodule: Cytology, surgical pathology, cell block, flow cytometry, molecular.\n\nRLL BAL: Cultures.\n\nIMPRESSION / PLAN\n\nEBUS staging performed with ROSE confirming Malignant NSCLC NOS at multiple stations. \n\nRLL nodule sampled via Galaxy robotic bronchoscopy; ROSE benign (lymphocytes) but final pathology pending. \n\nPatient discharged home after recovery with standard precautions.\n\nFollow-up in 1-2 weeks to review pathology results."
  },
  {
    "id": "example_16",
    "input_text": "Dx: Transplant stenosis RMS Procedure: Rigid dilation Steps: GA, ETT placed. Looked with flex scope, saw tight RMS stenosis.. Put in rigid scope. Used rigid dilators 7, 9, 11 mm.. Opened up to ~12mm.. No bleeding.Plan: Obs, surveillance bronch in a month.",
    "ideal_output": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name]\n\nINDICATION FOR OPERATION [Patient Name] is a [Age]-year-old [Sex] who presents with right mainstem (RMS) transplant stenosis requiring therapeutic intervention. The nature, purpose, risks, benefits, and alternatives to the procedure were discussed with the patient in detail. The patient wished to proceed and informed consent was obtained.\n\nCONSENT Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient or surrogate.\n\nPREOPERATIVE DIAGNOSIS\n\nTransplant airway stenosis, Right Main Stem (RMS)\n\nPOSTOPERATIVE DIAGNOSIS\n\nTransplant airway stenosis, Right Main Stem (RMS)\n\nStatus post rigid dilation; airway patent to ~12 mm\n\nPROCEDURE\n\nFlexible Bronchoscopy\n\nRigid Bronchoscopy (Therapeutic)\n\nMechanical Dilation (Rigid)\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an independent trained observer throughout the procedure.\n\nESTIMATED BLOOD LOSS Minimal \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After induction of general anesthesia, a timeout was performed confirming patient identity, planned procedures, and laterality. An endotracheal tube (ETT) was placed.\n\nAirway Inspection and Flexible Bronchoscopy A flexible bronchoscope was introduced. A complete airway survey was performed. The right mainstem (RMS) was inspected, and a tight transplant stenosis was visualized.\n\nRigid Bronchoscopy and Dilation The rigid bronchoscope was introduced via the mouth under direct visualization. The stenosis at the RMS was engaged.\n\nSequential mechanical dilation was performed using rigid dilators. The stenosis was dilated progressively using 7 mm, 9 mm, and 11 mm dilators. Following the intervention, the airway was inspected and estimated to be patent to approximately 12 mm.\n\nCompletion Hemostasis was confirmed. The bronchoscope and adjunct instruments were withdrawn. The patient tolerated the procedure well without immediate complications.\n\nIMPRESSION / PLAN\n\nRight mainstem (RMS) transplant stenosis identified.\n\nSuccessful rigid dilation performed using 7, 9, and 11 mm dilators; airway opened to ~12 mm.\n\nNo bleeding or immediate complications observed.\n\nPlan: Observation.\n\nSurveillance bronchoscopy scheduled in one month."
  },
  {
    "id": "example_17",
    "input_text": "Indication: Exudative effusion (neg cytology),Proc: Right Dx Thoracoscopy,- Findings: Pleural plaques,- Fluid evacuated,- Chest tube placed.",
    "ideal_output": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name]\n\nINDICATION FOR OPERATION [Patient Name] is a [Age]-year-old [Sex] who presents with an exudative effusion (negative cytology) requiring diagnostic evaluation. The nature, purpose, risks, benefits, and alternatives to the procedure were discussed with the patient in detail.\n\nCONSENT Obtained before the procedure. Indications, potential complications, and alternatives were discussed. The patient or surrogate signed the consent form.\n\nPREOPERATIVE DIAGNOSIS\n\nExudative pleural effusion (negative cytology)\n\n[Additional ICD-10 if applicable]\n\nPOSTOPERATIVE DIAGNOSIS\n\nExudative pleural effusion\n\nPleural plaques identified\n\nPROCEDURE\n\nRight Medical Thoracoscopy (Diagnostic) \n\nEvacuation of pleural fluid\n\nChest tube placement\n\nATTENDING [Name]\n\nASSISTANT [Fellow name]\n\nANESTHESIA [General anesthesia / airway type]\n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an independent trained observer throughout the procedure.\n\nPROCEDURE IN DETAIL After the successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedure, and laterality. Relevant procedural images were saved to the medical record.\n\nRight Diagnostic Thoracoscopy The chest was prepped and draped in the usual sterile fashion.\n\n\nSurvey: Thoracoscopic survey performed.\n\n\nFindings: Initial thoracoscopic survey demonstrates pleural plaques.\n\n\nIntervention: Pleural fluid was evacuated.\n\n\nClosure: Chest tube left in situ.\n\nThe patient tolerated the procedure well. There were no immediate complications.\n\nSPECIMENS\n\nPleural fluid (for analysis)\n\n[Pleural Biopsies if taken - standard for Dx Thoracoscopy but not explicitly requested in prompt]\n\nIMPRESSION / PLAN\n\nRight diagnostic thoracoscopy performed for exudative effusion (negative cytology).\n\nVisual findings consistent with pleural plaques.\n\nFluid successfully evacuated and chest tube placed.\n\nPost-procedure monitoring per protocol; obtain post-procedure chest imaging."
  },
  {
    "id": "example_18",
    "input_text": "Ion Bronch RUL + Chartis LUL,- Navigated to RUL anterior seg (1.4cm nodule) w/ Ion,- Confirmed w/ CBCT,- TBNA x6, Cryo x5,- BAL RUL,- Chartis LUL: CV Negative (no flow),- No complications.",
    "ideal_output": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION [Patient Name] is a [Age]-year-old [Sex] who presents with a 1.4 cm RUL pulmonary nodule requiring bronchoscopic diagnosis and staging, as well as assessment for potential lung volume reduction. The nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail. The patient wished to proceed and informed consent was obtained.\n\nCONSENT Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient or surrogate. Consent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\n\nRUL pulmonary nodule, 1.4 cm anterior segment\n\n[Additional ICD-10 if applicable, e.g., COPD/Emphysema]\n\nPOSTOPERATIVE DIAGNOSIS\n\nRUL pulmonary nodule, 1.4 cm anterior segment\n\nLUL Chartis assessment completed (CV Negative)\n\nPROCEDURE\n\nRobotic navigational bronchoscopy (Ion) to RUL target\n\nCone-beam CT imaging with confirmation\n\nTBNA of RUL target (6 passes)\n\nTransbronchial cryobiopsy of RUL target (5 samples)\n\nBronchoalveolar Lavage (BAL) RUL\n\nChartis assessment for collateral ventilation (LUL)\n\nATTENDING [Name]\n\nASSISTANT [Fellow name]\n\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA [General anesthesia / airway type]\n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an independent trained observer throughout the procedure.\n\nINSTRUMENTATION Ion robotic bronchoscopy platform; TBNA needles; cryobiopsy system; cone-beam CT system (Cios) / fluoroscopy; Chartis system.\n\nESTIMATED BLOOD LOSS Minimal \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and laterality. Relevant procedural images were saved to the medical record.\n\nRobotic Navigational Bronchoscopy (Ion) — RUL Nodule A CT-based navigation plan was loaded and robotic registration was completed. The Ion catheter was advanced under navigational guidance to the planned RUL anterior segment target (1.4 cm).\n\n\nCone-beam CT imaging: A 3D spin was obtained to evaluate catheter-to-target alignment.\n\n\nConfirmation: A subsequent cone-beam CT spin confirmed tool position within the lesion.\n\nRUL Target Sampling\n\n\nTBNA: 6 passes obtained from the RUL target.\n\n\nCryobiopsy: 5 transbronchial cryobiopsy samples obtained from the RUL target.\n\nBAL: Bronchoalveolar lavage was performed in the RUL with saline instilled and returned. Specimens were submitted.\n\nHemostasis was confirmed after sampling.\n\nChartis Assessment The Chartis system was used to assess for collateral ventilation.\n\nTarget: Left Upper Lobe (LUL).\n\nFindings: CV Negative (no flow) observed.\n\nFinal Assessment Final airway inspection demonstrated no clinically significant bleeding. No immediate complications occurred.\n\nSPECIMENS\n\nRUL nodule TBNA (6 passes) — cytology\n\nRUL transbronchial cryobiopsy (5 samples) — histology\n\nRUL BAL fluid — [analysis type]\n\nIMPRESSION / PLAN\n\nRUL anterior segment nodule (1.4 cm) successfully sampled with cone-beam CT confirmation; obtained TBNA x6 and Cryobiopsy x5.\n\nBAL performed in RUL.\n\nChartis assessment of LUL demonstrated CV Negative (no flow).\n\nAwait final pathology and cytology.\n\nPost-procedure monitoring per protocol; obtain post-procedure chest imaging to assess for PTX per local workflow."
  },
  {
    "id": "example_19",
    "input_text": "[INDICATION],Primary: Peripheral lung nodule with suspicious mediastinal nodes, Category: Lung Cancer Staging, Target: 19.4mm Solid lesion, RUL anterior (B3),Bronchus Sign: Positive, PET SUV: 6.7,,[ANESTHESIA],Type: General endotracheal anesthesia, ASA Class: 2, Airway: 8.0mm ETT, Duration: 131 minutes, , [DESCRIPTION], Procedure 1: Linear EBUS-TBNA, - Scope: Olympus BF-UC180F, - Needle: 19G FNB/ProCore, - Stations sampled: 10R, 2L, 11L, - Number of stations: 3 (≥3), - ROSE available: Yes, - ROSE result: Malignant - adenocarcinoma, , Procedure 2: Robotic Bronchoscopy, - Platform: Monarch (Auris Health (J&J)), - Registration: CT-to-body, error 1.5mm, - Target: RUL anterior (B3), , Procedure 3: Radial EBUS, - View: Concentric, - Confirmation: Augmented fluoroscopy, , Procedure 4: Transbronchial Biopsy, - Forceps biopsies: 6, - TBNA passes: 3, - Brushings: 2, - ROSE result: Granuloma, , Specimens: Cytology, cell block, surgical pathology, BAL cultures, Complications: None, EBL: <10mL, , [PLAN], 1. Post-procedure monitoring x2 hours, 2. Chest X-ray - completed, no pneumothorax, 3. Discharge to home if stable, 4. Follow-up: 1-2 weeks for pathology, 5. Tumor board review pending final results, 6. Molecular testing if malignancy confirmed",
    "ideal_output": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Referred Physician Name]\n\nINDICATION FOR OPERATION The patient presents with a 19.4mm solid peripheral lung nodule in the RUL anterior segment (B3) with a positive bronchus sign and suspicious mediastinal nodes (PET SUV: 6.7) requiring diagnosis and staging. The nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail.\n\nCONSENT Obtained before the procedure. Its indications, potential complications, and alternatives were discussed with the patient or surrogate. The patient or surrogate read and signed the provided consent form. The consent was witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\n\nPeripheral lung nodule, RUL (19.4mm, Solid)\n\nMediastinal lymphadenopathy\n\nPOSTOPERATIVE DIAGNOSIS\n\nAdenocarcinoma (mediastinal lymph nodes per ROSE)\n\nGranuloma (RUL nodule per ROSE)\n\nPROCEDURE\n\nRobotic navigational bronchoscopy (Monarch)\n\nRadial EBUS (Concentric view)\n\nLinear EBUS-TBNA (Stations 10R, 2L, 11L)\n\nTransbronchial Biopsy, TBNA, and Brushing\n\nROSE (Rapid On-Site Evaluation)\n\nANESTHESIA General endotracheal anesthesia (ASA Class 2). Airway: 8.0mm ETT. Duration: 131 minutes.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nESTIMATED BLOOD LOSS <10mL.\n\nCOMPLICATIONS None.\n\nPROCEDURE IN DETAIL\nAfter the successful induction of general anesthesia, a timeout was performed confirming the patient's name, procedure type, and procedure location. An 8.0mm endotracheal tube was utilized.\n\nRobotic Navigational Bronchoscopy (Monarch) Robotic navigation bronchoscopy was performed using the Monarch platform (Auris Health, J&J). A navigation plan from the pre-procedure CT was loaded. Registration to the body was completed with an error of 1.5mm. The robotic catheter and sheath were advanced to the target in the RUL anterior segment (B3) under navigational guidance.\n\nTarget Confirmation and Sampling\n\nRadial EBUS: Radial EBUS verified a concentric position relative to the lesion.\n\nImaging: Augmented fluoroscopy was used for trajectory confirmation.\n\nSampling: Sampling through the working channel was performed as follows:\n\nTransbronchial Forceps Biopsy: 6 biopsies were obtained.\n\nTBNA: 3 passes were performed.\n\nBrushings: 2 samples were collected.\n\nROSE Results (Nodule): Preliminary review suggested Granuloma.\n\nLinear EBUS-TBNA Staging The Olympus BF-UC180F linear EBUS scope was introduced. A systematic mediastinal survey was completed. Sampling was performed using a 19G FNB/ProCore needle.\n\nStations Sampled: 10R, 2L, 11L (Total 3 stations).\n\nROSE Results (Nodes): Malignant - adenocarcinoma.\n\nCompletion Hemostasis was confirmed. The patient tolerated the procedure well without immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\n\nCytology\n\nCell block\n\nSurgical pathology\n\nBAL cultures\n\nIMPRESSION / PLAN\n\nRUL Nodule: Successfully sampled with concentric rEBUS view; ROSE suggests Granuloma.\n\nMediastinal Staging: EBUS-TBNA performed at 3 stations (10R, 2L, 11L); ROSE positive for Adenocarcinoma.\n\nPost-Procedure:\n\nPost-procedure monitoring x2 hours per protocol.\n\nChest X-ray completed; no pneumothorax identified.\n\nDischarge to home if stable.\n\nFollow-up:\n\nOffice follow-up in 1-2 weeks to review final pathology.\n\nCase to be reviewed at Tumor Board pending final results.\n\nMolecular testing will be requested given malignancy confirmation."
  },
  {
    "id": "example_20",
    "input_text": "OPERATIVE REPORT: Medical Thoracoscopy with Parietal Pleural Biopsy and Pleurodesis. INDICATIONS: Malignant pleural effusion staging. INTRAOPERATIVE FINDINGS: Extensive visceral pleural metastasis observed. Eleven biopsy specimens were harvested from the parietal surface for histopathological confirmation. Due to the malignant appearance, chemical pleurodesis was undertaken utilizing sterile talc insufflation. COMPLICATIONS: None. Hemostasis achieved.",
    "ideal_output": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT DATE OF PROCEDURE: [Date] CC Referred Physician: [Name] INDICATION FOR OPERATION [Patient Name] is a [Age]-year-old [Sex] who presents with malignant pleural effusion staging. The nature, purpose, risks, benefits, and alternatives to the procedure were discussed with the patient in detail.  CONSENT Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient or surrogate. Consent was signed and witnessed by an assisting medical professional. \n\nPREOPERATIVE DIAGNOSIS\n\nMalignant pleural effusion\n\n[Additional ICD-10 if applicable]\n\nPOSTOPERATIVE DIAGNOSIS\n\nMalignant pleural effusion\n\nExtensive visceral pleural metastasis identified\n\nPROCEDURE\n\nMedical Thoracoscopy (Pleuroscopy) \n\nParietal Pleural Biopsy (11 specimens) \n\nChemical Pleurodesis (Talc Insufflation) \n\nATTENDING [Name]\n\nASSISTANT [Fellow name] \n\nSUPPORT STAFF RN: [Name] RT: [Name] \n\nANESTHESIA [General anesthesia / Moderate Sedation] \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an independent trained observer throughout the procedure. \n\nESTIMATED BLOOD LOSS Minimal \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After the successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and laterality. Relevant procedural images were saved to the medical record. \n\nMedical Thoracoscopy A thoracoscopic survey was performed.  Intraoperative findings demonstrated extensive visceral pleural metastasis. Based on the visual appearance, biopsies were taken from the parietal surface.  Eleven (11) biopsy specimens were harvested for histopathological confirmation.\n\nPleurodesis Due to the malignant appearance of the pleura, chemical pleurodesis was performed.  Sterile talc insufflation was utilized to achieve pleurodesis. Hemostasis was confirmed. The patient tolerated the procedure well without immediate complications. \n\nSPECIMENS\n\nParietal pleural biopsy (11 specimens) — histology \n\nIMPRESSION / PLAN\n\nMedical thoracoscopy completed for malignant pleural effusion staging.\n\nExtensive visceral pleural metastasis visualized; 11 parietal pleural biopsies obtained.\n\nTalc pleurodesis performed via insufflation.\n\nAwait final pathology. \n\nPost-procedure monitoring per protocol."
  },
  {
    "id": "example_21",
    "input_text": "57yo female here for bronch w EBUS staging and robotic biopsy of a 14.5mm RUL nodule that was ground-glass on CT, bronchus sign was positive, no PET done. under general we did linear EBUS first using the Fujifilm EB-580S scope with 19g needle and sampled stations 11L x4, 7 x2, 2L x3, ROSE was there and showed Malignant - NSCLC NOS at multiple stations. then switched to Monarch robot and navigated to the RUL anterior (B3) lesion, registration was 3.2mm which is fine, got radial EBUS showing concentric view and did tool in lesion confirmation with radial ebus. took 7 forceps bx, 4 needle passes, brushings x2, BAL sent for cultures. ROSE from the nodule was Atypical cells. no bleeding no ptx   patient did well specimens to path for cyto, surgical path, cell block, flow, molecular if needed d/c home after recovery with standard precautions, f/u 1-2wks for path Brian O'Connor md\nip attending",
    "ideal_output": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] ATTENDING: Brian O'Connor, MD INDICATION FOR OPERATION The patient is a 57-year-old female who presents with a 14.5 mm RUL pulmonary nodule (ground-glass on CT, positive bronchus sign, no PET performed) requiring bronchoscopic diagnosis and staging. The nature, purpose, risks, benefits, and alternatives to bronchoscopy were discussed with the patient in detail. The patient wished to proceed and informed consent was obtained.\n\nCONSENT Obtained before the procedure. Indications, potential complications, and alternatives were discussed with the patient or surrogate. Consent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\n\nRUL pulmonary nodule, 14.5 mm (Ground-glass opacity)\n\nPOSTOPERATIVE DIAGNOSIS\n\nRUL pulmonary nodule (Atypical cells on ROSE)\n\nMalignant lymphadenopathy (NSCLC NOS on ROSE)\n\nPROCEDURE\n\nRobotic navigational bronchoscopy (Monarch) to RUL target\n\nRadial EBUS localization\n\nTransbronchial forceps biopsy (7 samples)\n\nTransbronchial needle aspiration (4 passes)\n\nBronchial brushings (2 samples)\n\nBronchoalveolar lavage (BAL)\n\nEBUS-TBNA staging (Stations 11L, 7, 2L) using 19-gauge needle\n\nANESTHESIA General anesthesia.\n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an independent trained observer throughout the procedure.\n\nESTIMATED BLOOD LOSS Minimal\n\nCOMPLICATIONS None (No bleeding, no pneumothorax).\n\nPROCEDURE IN DETAIL After induction of general anesthesia, a timeout was performed confirming patient identity, planned procedures, and laterality.\n\nEBUS STAGING The EBUS bronchoscope (Fujifilm EB-580S) was introduced and a systematic mediastinal/hilar survey was performed. The following lymph node stations were identified and sampled using a 19-gauge needle:\n\nStation 11L: Sampled 4 times. ROSE result: Malignant - NSCLC NOS.\n\nStation 7: Sampled 2 times. ROSE result: Malignant - NSCLC NOS.\n\nStation 2L: Sampled 3 times. ROSE result: Malignant - NSCLC NOS.\n\nROBOTIC NAVIGATIONAL BRONCHOSCOPY (Monarch) — RUL Nodule Robotic navigation bronchoscopy was performed using the Monarch platform. Pre-procedure CT-based plan was loaded and airway registration completed. Registration error was noted to be 3.2 mm. The robotic catheter and sheath were advanced to the RUL anterior (B3) target under navigational guidance.\n\nRadial EBUS: Confirmed concentric view. Tool-in-lesion was confirmed with radial EBUS.\n\nSampling:\n\nForceps Biopsy: 7 samples obtained.\n\nNeedle Aspiration: 4 passes obtained.\n\nBrushings: 2 samples obtained.\n\nBAL: Sent for cultures.\n\nROSE (Nodule): Atypical cells.\n\nHemostasis was confirmed. The patient tolerated the procedure well.\n\nSPECIMENS\n\nStation 11L, 7, 2L EBUS-TBNA (Cytology, ROSE)\n\nRUL Nodule Biopsies (Cytology, Surgical Pathology, Cell Block)\n\nBAL (Cultures)\n\nAdditional studies: Flow cytometry, Molecular if needed.\n\nIMPRESSION / PLAN\n\nSuccessful robotic bronchoscopy and sampling of RUL nodule (14.5 mm) with concentric rEBUS confirmation. ROSE showed Atypical cells.\n\nEBUS staging performed with 19G needle; ROSE showed Malignancy (NSCLC NOS) at multiple stations (11L, 7, 2L).\n\nNo bleeding or pneumothorax noted.\n\nAwait final pathology and cytology.\n\nDischarge home after recovery with standard precautions.\n\nFollow-up in 1-2 weeks for pathology results."
  },
  {
    "id": "example_22",
    "input_text": "Proc: Tunneled Pleural Catheter (Right).  Indication: Malignant effusion (Ovarian CA).  US marked.  15.5Fr PleurX placed.  Drained 1.1L clear yellow fluid.  CXR: Good pos.",
    "ideal_output": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] INDICATION FOR OPERATION The patient presents with a malignant pleural effusion secondary to Ovarian Cancer requiring drainage and symptom management. The nature, purpose, risks, benefits, and alternatives to the procedure were discussed with the patient in detail.\n\nPREOPERATIVE DIAGNOSIS\n\nMalignant Pleural Effusion (Ovarian CA) \n\nPOSTOPERATIVE DIAGNOSIS\n\nMalignant Pleural Effusion (Ovarian CA) \n\nStatus post right tunneled pleural catheter placement\n\nPROCEDURE\n\nIndwelling Tunneled Pleural Catheter Placement (Right) \n\nThoracic Ultrasound \n\nANESTHESIA Local anesthesia (Lidocaine 1%) \n\nESTIMATED BLOOD LOSS Minimal \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL Chest Ultrasound Findings\n\n\nHemithorax: Right \n\n\nFindings: Pleural effusion identified and site marked for procedure.\n\nCatheter Placement The right chest was prepped and draped in sterile fashion. Local anesthesia was infiltrated at the insertion site. A finder needle was used to enter the pleural space; pleural fluid was aspirated to confirm location. The needle was withdrawn and a guidewire was placed into the pleural space.\n\nTwo 5 mm skin incisions were made at the guidewire entry site, as well as 5-6 cm away. The tunneling device was used to tunnel the catheter in the subcutaneous tissue. Serial dilation over the guidewire was then achieved. The introducer sheath was placed and the guidewire removed.\n\nThe 15.5Fr PleurX catheter was then placed into the pleural space via the introducer sheath. The pleural entry site was closed with an absorbable suture. The catheter was secured to the skin using 2-0 nylon. Sterile dressings were applied.\n\nPROCEDURE FINDINGS\n\n\nFluid Removed: 1100 mL (1.1 L) \n\n\nAppearance: Clear yellow (Serous) \n\nIMPRESSION / PLAN\n\nSuccessful placement of Right 15.5Fr Indwelling Tunneled Pleural Catheter (PleurX).\n\n1.1 L of clear yellow fluid drained during procedure.\n\nPost-procedure chest x-ray confirmed good position.\n\nCatheter instructions and drainage kit provided to patient."
  }
]